US Patent Number

9326983

Publication Date

5-3-2016

Abstract

The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates to methods for treating degradation of the retinal pigment epithelium by administering compositions comprising a nucleoside and/or a nucleoside or nucleotide reverse transcriptase inhibitor.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

14/450,000

Filing Date

08/01/2014

Included in

Ophthalmology Commons

Share

COinS